Sorrento Therapeutics Inc (NASDAQ: SRNE) shares were headed higher Thursday following an announcement concerning its antibody test kit for SARS-CoV-2, the virus that causes COVID-19. What Happened ...

The Food and Drug Administration (FDA) has warned consumers to stop using an unauthorized COVID-19 at-home rapid test and antibody test over concerns that the kits may produce false results.

Siemens Healthineers started shipping its total antibody tests globally ... s real-time PCR molecular SARS-CoV-2 detection test kit, which demonstrates 100 percent positive percent agreement ...

“National Institute of Virology, Pune, has successfully developed the 1st indigenous anti-SARS-CoV-2 human IgG ELISA test kit for antibody detection of COVID-19,” the minister said in one of a ...

Sorrento Therapeutics Inc SRNE shares were headed higher Thursday following an announcement concerning its antibody test kit for SARS-CoV-2, the virus that causes COVID-19. What Happened ...